Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of the fiscal period ended Sunday, December 31, 2023.
Reported annual fiscal-period values; no daily interpolation.
PEG RATIO
N/A
PEG RATIO AVG TTM
0.84
PEG RATIO AVG 3Y
0.69
PEG RATIO AVG 5Y
N/A
PEG RATIO AVG 10Y
N/A
PEG RATIO AVG 15Y
N/A
PEG RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$6.88B
PEG Ratio
N/A
TTM Avg
0.53
3Y Avg
0.53
5Y Avg
0.41
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hims & Hers Health, Inc. (HIMS) | $6.28B | N/A | 0.84 | 0.69 | N/A |
| Chemed Corporation (CHE)vs › | $6.78B | N/A | 3.14 | 3.14 | 2.77 |
| Scholar Rock Holding Corporation (SRRK)vs › | $6.88B | N/A | 0.53 | 0.53 | 0.41 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.22B | 8.41 | 5.09 | 3.27 | 2.83 |
| Doximity, Inc. (DOCS)vs › | $4.57B | 0.57 | 0.96 | 0.67 | 1.38 |
| Oscar Health, Inc. (OSCR)vs › | $8.56B | 0.01 | 0.01 | 0.07 | 0.12 |
| TransMedics Group, Inc. (TMDX)vs › | $3.05B | 0.05 | 0.05 | 1.65 | 1.32 |
| Insulet Corp. (PODD)vs › | $9.85B | 0.28 | 0.23 | 2.94 | 3.14 |
| The Ensign Group, Inc. (ENSG)vs › | $9.94B | 2.06 | 1.34 | 1.43 | 1.33 |
| Globus Medical, Inc. (GMED)vs › | $10.12B | 0.05 | 0.05 | 0.73 | 0.87 |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PEG RATIO |
|---|---|
| 2023-12-31 | 1.23 |
| 2022-12-31 | 0.45 |
| 2020-12-31 | 0.38 |
